Nintedanib and ischemic colitis: Signal assessment with the integrated use of two types of real‐world evidence, spontaneous reports of suspected adverse drug reactions, and observational data from large health‐care databases

PURPOSE: Statistical screening of Vigibase, the global database of individual case safety reports, highlighted an association between the MedDRA Preferred Term (PT) “colitis” and nintedanib. Nintedanib is a protein kinase inhibitor authorized in accelerated regulatory procedures for the treatment of...

Descripción completa

Detalles Bibliográficos
Autor principal: Chandler, Rebecca E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496543/
https://www.ncbi.nlm.nih.gov/pubmed/32399991
http://dx.doi.org/10.1002/pds.5022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496543/
https://www.ncbi.nlm.nih.gov/pubmed/32399991
http://dx.doi.org/10.1002/pds.5022

Ejemplares similares